Nathalie Donne - DBV Technologies Director
Director
Ms. Nathalie Donne serves as Director of Corporationrationrate Communication Business Development of DBV Technologies SA. She was Product Manager at the Company from 2003 to 2006, where she worked first Product Diallertest Milk then became Project Manager, the function she held between 2006 and 2009. She holds a degree in Biology from the University Paris VI France and a Masters degree in Biotechnology from Innovation Institut National Agronomique Paris and Reims Management School .
| Phone | 33 1 55 42 78 78 |
| Web | https://www.dbv-technologies.com |
DBV Technologies Management Efficiency
The company has return on total asset (ROA) of (31.96) % which means that it has lost $31.96 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (67.72) %, meaning that it generated substantial loss on money invested by shareholders. DBV Technologies' management efficiency ratios could be used to measure how well DBV Technologies manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 4.63 M in total debt with debt to equity ratio (D/E) of 0.06, which may suggest the company is not taking enough advantage from borrowing. DBV Technologies has a current ratio of 3.4, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DBV Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, DBV Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DBV Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DBV to invest in growth at high rates of return. When we think about DBV Technologies' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| John Carmola | Minerals Technologies | 65 | |
| Dionisio Paoletti | Cementos Pacasmayo SAA | 51 | |
| Joaquin Gubbins | Cementos Pacasmayo SAA | N/A | |
| Carlos Ramos | Cementos Pacasmayo SAA | 51 | |
| Toru Hambayashi | Fast Retailing Co | 80 | |
| Nestor Angulo | Cementos Pacasmayo SAA | N/A | |
| Marco Garcia | Cementos Pacasmayo SAA | 60 | |
| David Fynn | Flexible Solutions Internationa | 61 | |
| Nobumichi Hattori | Fast Retailing Co | 60 | |
| Alison Deans | Minerals Technologies | 59 | |
| Juan Vazquez | Cementos Pacasmayo SAA | N/A | |
| Dionisio Romero | Cementos Pacasmayo SAA | 51 | |
| Diego Apalategui | BBB Foods | 47 | |
| Naotake Ohno | Fast Retailing Co | 69 | |
| Luis Bermdez | BBB Foods | 53 | |
| Gianfranco Zuniga | Cementos Pacasmayo SAA | N/A | |
| Dale Friend | Flexible Solutions Internationa | 59 | |
| Robert Clark | Minerals Technologies | 57 | |
| Donald Winter | Minerals Technologies | 72 | |
| Alejandro Davila | BBB Foods | 46 | |
| Rolando Cueva | Cementos Pacasmayo SAA | N/A | |
Management Performance
| Return On Equity | -67.72 | |||
| Return On Asset | -31.96 |
DBV Technologies Leadership Team
Elected by the shareholders, the DBV Technologies' board of directors comprises two types of representatives: DBV Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DBV. The board's role is to monitor DBV Technologies' management team and ensure that shareholders' interests are well served. DBV Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DBV Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pascale Ehouarn, Industrial Development and Production Director | ||
| Claude Thebault, Medical Director | ||
| Wence Agbotounou, Chief Clinical Trial Officer | ||
| Laurent Martin, Director of Regulatory Affairs | ||
| Viviane Monges, Director | ||
| Didier Hoch, Director | ||
| Hugh Sampson, Chief Scientific Officer | ||
| Charles Ruban, Chief Development Officer | ||
| Nathalie Donne, Director of Bus. Devel. and Corporate Communication | ||
| Lucie Mondoulet, Director of Research Department | ||
| Chahra Louafi, Director - Representative of CDC Entreprises (Innobio) | ||
| Peter Hutt, Independent Director | ||
| Rafaele Tordjman, Director - Representative of Sofinnova Partners | ||
| Bertrand Dupont, Co-Founder and Sr. Executive VP of Technology | ||
| Veronique Foutel, Director of Strategic Marketing | ||
| FAAAAI MD, Chief Scientific Officer, Advisor and Member of The Scientific Advisory Board | ||
| Daniel Tasse, CEO, Director | ||
| Rafale Tordjman, Director - Representative of Sofinnova Partners | ||
| Joan Schmidt, Executive Vice President General Counsel | ||
| George Horner, Director | ||
| Torbjorn Bjerke, Independent Director | ||
| Pharis Mohideen, Chief Medical Officer | ||
| PierreHenri Benhamou, Chairman of the Board, CEO | ||
| Torbjrn Bjerke, Independent Director | ||
| Mailys Ferrere, Director | ||
| Michel Rosen, Director | ||
| David Schilansky, COO |
DBV Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is DBV Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -67.72 | |||
| Return On Asset | -31.96 | |||
| Operating Margin | (952.83) % | |||
| Current Valuation | 84.39 M | |||
| Shares Outstanding | 29.98 M | |||
| Shares Owned By Insiders | 6.53 % | |||
| Shares Owned By Institutions | 37.62 % | |||
| Price To Earning | (12.55) X | |||
| Price To Book | 1.88 X | |||
| Price To Sales | 11.03 X |
Pair Trading with DBV Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DBV Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DBV Technologies will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to PGE Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PGE Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PGE Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PGE Corp to buy it.
The correlation of PGE Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PGE Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PGE Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PGE Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in DBV OTC Stock
If you are still planning to invest in DBV Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DBV Technologies' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Transaction History View history of all your transactions and understand their impact on performance |